ADAMTS13 and thrombotic thrombocytopenic purpura: Cataland et al. reported that ADAMTS‐13 levels < 10% were 100% sensitive and 100% specific for TTP in a cohort of 57 patients compared with 57 TMA patients with alternative diagnoses 10.